Premium
Recent advances in etoposide therapy for non‐small cell lung cancer
Author(s) -
Bonomi Philip
Publication year - 1991
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19910101)67:1+<254::aid-cncr2820671308>3.0.co;2-v
Subject(s) - medicine , etoposide , chemotherapy , lung cancer , disease , oncology , stage (stratigraphy) , cancer , intensive care medicine , paleontology , biology
Non‐small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of chemotherapy treatments have been evaluated in patients with advanced NSCLC. The objective of this review is to summarize the results of the chemotherapy trials in Stage III and IV NSCLC patients.